Background. Clear visibility of the needle and catheter tip is desirable to perform safe and successful ultrasound-guided peripheral nerve blocks. This can be challenging with deeper blocks in obese patients. This study compared the visibility of echogenic and non-echogenic block needles and catheters in proximal sciatic blocks when performed with a low-frequency curved probe.
Editor's key points
• The use of ultrasound for peripheral nerve blocks may increase success rate and speed.
• This randomized controlled trial compared the performance of echogenic with non-echogenic block needles.
• Echogenic needle and catheter systems were faster than stimulating systems, with less patient discomfort.
• Further study is needed to establish the role of the echogenic systems in regional anaesthesia.
Awareness of the precise location of the needle and catheter tip is desirable for performing safe and successful peripheral nerve blocks. Current techniques used to determine the needle and catheter tip location include use of electrical nerve stimulation and ultrasonography; each technique has its own benefits and drawbacks. With ultrasonography, failure to see the needle tip is the commonest error, which continues to be a problem even after experience of performing >100 blocks. 1 Use of ultrasound (US) can be particularly challenging with deep blocks because the angle of needle insertion is steep, which has been shown to markedly degrade visibility of the tip and the shaft. 2 3 Echogenic needles and catheters are of similar design to the existing peripheral nerve block needles but have the potential advantage of improved visibility during US imaging.
In comparison with neurostimulation, ultrasonography has been shown to reduce procedural time and improve success rates in some studies and not to worsen them in others. [4] [5] [6] Use of stimulating catheters has been shown to improve block success rates compared with use of non-stimulating catheters, 7 but this was without the use of US. When purely US-guided needle and continuous catheter placement has been compared with purely nerve stimulator-guided needle and catheter placement, reductions in procedure time with similar or improved block success rates have been shown. [8] [9] [10] Commonly available block catheters are often not clearly seen by US, and echogenic catheters have the potential for improved visibility. Whether the technological improvement with needle and catheter visibility makes a difference to success of peripheral nerve blocks has not been extensively investigated. Damage to nerves and surrounding structures is a significant clinical concern with deep blocks, such as proximal sciatic blocks, where there can be difficulty in needle visualization because of anatomical considerations and acute angles of insonation. Electrical nerve stimulation can be unreliable, leading to unnecessary needle movements during the process of attaining the desired muscle twitch end points. 11 12 One study has documented better needle visibility with echogenic needles compared with non-echogenic needles for femoral and sciatic nerve blocks. 2 That study used only linear mid-to high-frequency transducers (>5 MHz). Visualization of deeper structures requires the use of a low-frequency probe. There are no studies that have compared echogenic catheters with stimulating catheters with regard to catheter visibility, safety, and success rate of blocks. We wanted to compare the visibility of echogenic needles and echogenic catheters (Sonolong, Pajunk ® GmBH, Geisingen, Germany) with non-echogenic needles and stimulating catheters (Stimulong NanoLine Plexus catheter set; Pajunk ® ) with regard to visibility, safety, and efficacy when used for proximal sciatic nerve blocks with a low-frequency (2-5 MHz) curved probe. The primary outcome of our study was the visibility of the needle on initial contact with the nerve.
Secondary outcomes were block performance characteristics and catheter visibility.
Methods
After local Institutional review board approval (HSREB 17757) and registration with ClinicalTrials.Gov (NCT 01492660), patients of ages 18-80 yr with ASA ratings I-IV and undergoing unilateral total knee joint arthroplasty were reviewed before surgery to assess suitability to receive continuous peripheral nerve block for postoperative analgesia. Exclusion criteria included contraindications to regional anaesthesia (local infection, coagulopathy), allergy to study medications, diabetic neuropathy, pre-existing nerve injury, and pregnancy. Randomization and allocation concealment were achieved by means of placing group assignment labels into envelopes, which were then sealed and thoroughly shuffled before being sequentially numbered. Allocation was to either the control ('Stimulating') group or the intervention ('Echogenic') group (CONSORT diagram; Fig. 1 ). Participants and evaluators of the visibility of needles and catheters were blinded to group allocation. Participants randomized to the stimulating group had the sciatic nerve blocks performed with a Pajunk stimulating needle and stimulating catheter (Stimulong NanoLine Plexus catheter set; Pajunk ® ). Those randomized to the echogenic group had the sciatic block performed using a Pajunk stimulating echogenic needle and non-stimulating echogenic catheter (Sonolong; Pajunk ® ). Procedures were performed in a block room using standard monitors, including non-invasive blood pressure and pulse oximetry. All patients received supplemental oxygen and titrated conscious sedation with fentanyl and midazolam. All participants initially received a continuous femoral nerve block using US guidance (Sonosite M Turbo, Bothell, WA, USA) and a stimulating catheter (Arrow; Teleflex Medical, Research Triangle Park, NC, USA) whilst in the supine position. After siting of the femoral catheter, patients were moved to the lateral decubitus position with the operative side uppermost for the proximal sciatic nerve block. In both groups, a pre-procedural scan was performed using a 2-5 MHz curved array probe placed at the level of the greater trochanter, and the US view was adjusted until the ischial tuberosity could also be seen, with the sciatic nerve lying deep to the subgluteal fascia and superficial to the quadratus femoris muscle (Fig. 2) . The point of needle entry was marked adjacent to the lateral aspect of the probe. The skin was prepared with chlorhexidine 2% in alcohol 70%. The US probe was covered using a sterile probe cover and positioned to obtain the best possible image of the sciatic nerve in short axis. The 18 gauge block needle was inserted in a lateral-to-medial direction in plane with the ultrasound beam. The needle position was confirmed using neurostimulation by obtaining an appropriate twitch in the sciatic distribution ( plantarflexion, dorsiflexion, eversion, or inversion of the foot) at a current intensity between 0.2 and 0.6 mA. The needle position was also confirmed with hydrolocation by injection of dextrose 5% (1-2 ml) through the needle. After this, the catheter was advanced through the needle. The catheters in the Echogenic group were positioned under US guidance alone, whereas the catheters in the Stimulating group were guided into position solely by maintenance of muscle twitches during catheter advancement. In the Echogenic group, the catheter was inserted by a second anaesthetist using US guidance alone to a maximal distance of 4 cm beyond the tip of the needle. A colour Doppler interrogation was performed by injecting agitated dextrose 5% (2-5 ml) to assess the catheter tip location in both groups (Fig. 3 ). Once the catheter was deemed appropriately positioned, mepivacaine 2% (20 ml) was injected, with aspiration repeated after every 5 ml. The entire procedure was recorded as a video clip using the inbuilt recording function of the Sonosite M-Turbo. Finally, the sciatic nerve was imaged in short and long axis to assess the spread of local anaesthetic (LA) around the nerve (Fig. 4) . The patients were then asked to grade the degree of discomfort perceived during the performance of the block on a categorical scale of none, mild, moderate or severe. A flowchart to clarify the differences between the groups is shown in Supplementary material Figure S1 . All blocks were performed or directly supervised by a consultant anaesthetist with extensive experience in superficial and deep continuous peripheral nerve block insertion. Supervised blocks were performed by fellows in regional anaesthesia with at least 3 months in-post experience. The research assistant documented the start and finish time of the block procedure in addition to the number of attempts and redirections based on predetermined criteria (given below). The time to the end of LA injection was also documented. The research assistant documented the motor and sensory block at 5 min intervals until the block was complete, or to a maximum of 30 min. Sensory block was tested using pinprick sensation and compared with the contralateral leg in the following four areas: the plantar aspect of the foot; the posterior aspect of the calf; the dorsum of the foot; and the first toe web space. Sensory block was scored for each area on a 0-2 scale, where 0=no anaesthesia, 1=hypoesthesia, and 2=complete anaesthesia for a maximal total score of 8. Motor block was assessed using the following movements: foot dorsiflexion and plantarflexion; foot eversion and inversion; and knee flexion. Motor block was scored on a scale of 0-2 for each movement, where 0=full strength, 1=reduced strength, and 2=no movement. Scores for each movement were summed to give a maximal total score of 10.
Recorded video clips were de-identified and sent along with the data collection form to three co-investigators (K.A., S.D., and V.U.) who were blinded to group allocation. The observers were required to grade the visibility of the nerve, and the visibility of the needle tip and shaft on initial needle contact (before any injection) with the nerve on a 3-point scale, as follows: 1 was poorly visible or barely distinguishable from the surrounding parenchyma; 2 was visualization with difficulty but noticeably more echogenic than surrounding tissues; and 3 was clear visibility with strong echogenicity compared with surrounding tissues. Visibility of the needle tip and shaft was again recorded after dextrose was injected to confirm needle tip location.
The observers were asked to identify whether the catheter tip was visible; whether or not the colour Doppler signal indicated acceptable catheter tip position as defined by a Doppler signal adjacent to the nerve on injecting the dextrose; and whether the spread of LA was adequate or inadequate, with adequate spread being arbitrarily defined as circumferential spread covering 360°around the nerve in short axis and along a 2 cm length of the nerve long axis on either side.
After 30 min of the testing process, patients received either a spinal or a general anaesthetic for the surgical procedure at the discretion of the patient and attending anaesthetist. After surgery, an infusion of ropivacaine 0.1% (4 ml h −1 ) was commenced via the sciatic catheter. Patients were followed up by telephone 1 week after discharge from hospital to check for symptoms of residual neurological dysfunction. The primary outcome was designated at the design stage of the study to be visibility of the block needle at the time of initial nerve-needle contact according to the blinded observers. Secondary outcomes included the following parameters: time from first needle contact with skin to first acceptable muscle response to nerve stimulation; time from first needle contact with skin to completion of catheter insertion (total procedure time); patient perception of discomfort during the block; number of needle redirections required to locate the needle optimally (redirection being defined as every movement that followed a needle withdrawal of >2 cm); number of skin punctures made; number of catheter reinsertions required; block onset time; block success rate (as judged by neurological testing every 5 min up to 30 min); and incidence of vascular puncture. The block was considered complete if the total score of motor and sensory block was at least 16 out of 18, incomplete if the total score was between 5-15, and a failure if the total score was between 0 and 4. The time to block onset was defined as the time from completion of LA injection to the time a total score of ≥5 was achieved. The time to block completion was defined as the time from completion of LA injection to time to reach a total score of >15.
Statistical analysis
According to the results of Bergin and colleagues, 13 the expected proportion of needle tips in the control (Stimulating) group judged as 'clearly visualized' would be 0.32. The expected proportion of clearly seen needle tips in the experimental (Echogenic) group would be 0.66. To have 80% power to detect this difference with a level of significance of 0.05, 30 patients per group were required. To allow for a loss of five patients per group, 35 patients per group were planned. Categorical data for the primary and secondary hypotheses were tested using Fisher's exact test. Variables related to block performance and block characteristics (number of skin punctures, needle and catheter redirects, vascular punctures, time to first muscle twitch, time for completion of LA injection, and block performance time) were analysed using the Wilcoxon two-sample test. Anaesthesia onset and completion times were analysed using the log-rank test. The visibility scores rated by three independent observers were summarized for each patient (mean score) and compared between the two groups using a Wilcoxon two-sample test that allows for clustering. For binary outcomes, a generalized estimating equation approach was used to compare groups while adjusting for clustering that resulted from multiple observations per patient. 14 SAS 9.3 (SAS Institute Inc., Cary, NC, USA) was used for statistical analysis, and P < 0.05 was considered significant.
Results
A total of 189 patients were assessed for eligibility; 78 were randomized, and 73 were analysed ( Fig. 1; CONSORT diagram) .
Owing to a technical error that resulted in failure of ultrasound video recording of the first five patients, ethical approval was granted to recruit a further eight participants (78 participants in total), resulting in the two arms of the study being unequal in size. Participant characteristics are shown in Table 1 for all 78 participants. Study results are shown for the 73 participants whose ultrasound images were successfully recorded. Participant characteristics were similar in the two groups (Table 1) .
Visibility-related outcomes scored independently by the three blinded anaesthetists are shown in Table 2 . There were no differences between the two groups with regard to needle tip and shaft visibility, nerve visibility, catheter visibility, colour Dopplerassessed catheter tip location, and adequacy of LA dispersion around the nerve.
Procedure performance and block characteristics are given in Table 3 . The Stimulating group had a higher number of needle redirects (P=0.009). The Echogenic group required less time to complete the block procedure (P=0.016), and fewer patients in this group reported discomfort during the procedure (P=0.012). All other block parameters were comparable between the two groups.
There were four failed blocks in the Echogenic group (score <5/18) and none in the Stimulating group, whereas the number of patients with incomplete (score 5-15/18) and complete blocks (score of >15/18) were comparable between the groups (P=0.104). The overall onset (P=0.119) and completion times (P=0.062) were similar in both the groups (Fig. 5) . Our block testing was carried out only up to 30 min, and the incomplete blocks were extrapolated to 50 min for the purposes of graphical representation.
Two patients in the Echogenic group suffered complications. One patient experienced paraesthesia of the sole of the foot, which had resolved completely at 3 weeks. The other patient became unresponsive after intravascular injection of LA during the sciatic block. Intralipid was administered and rapid return to full consciousness occurred with no further sequelae. One patient in the Stimulating group suffered a fall on the first postoperative day, ascribed to quadriceps weakness as a result of the femoral nerve block.
Discussion
The present study evaluated the visibility of echogenic and nonechogenic block needles and catheters during proximal sciatic blocks. There were no significant differences in the visibility scores between the two groups. Stimulating catheters took longer to site, required more needle redirections, and were reported by patients to result in more discomfort than when echogenic catheters were used. The onset and completion times were not different between the two groups. The Echogenic group had four block failures.
Obesity has reached epidemic proportions (32-36% of adults), and an increasing proportion of these patients will undergo lower limb arthroplasty. [15] [16] [17] In a recent review on obesity and total joint arthroplasty, >50% of the patients undergoing knee replacement surgeries were found to be obese. 18 Sciatic nerve blocks are often performed to provide analgesia for lower limb operations, including total knee arthroplasty. Proximal sciatic blocks are known to be challenging technically because of a variety of factors. These factors include the depth of the target nerve, the steep angle of needle insertion, and the loss of US beam energy to the intervening tissues from diffraction, absorption, and attenuation. 19 These factors are exaggerated in obese patients, increasing the technical challenge of performing nerve blocks. Inability to see the entire needle, including the tip, is a major source of error even for experienced operators. 1 If this visualization is inadequate, more proximal parts of the needle can be mistaken for the needle tip, with the result that structures can inadvertently be traumatized, and intraneural or intravascular LA deposition can occur. Technological adjuncts leading to improved needle contrast relative to the surrounding tissue, including echogenic technologies or beam steering, may improve the safety and efficacy of these challenging blocks. These technologies often come with an increased financial cost, but whether or not they improve safety and efficacy is currently unknown. Although US guidance has not been shown to reduce the incidence of neurological injury after peripheral nerve blocks, 20 spects. In our study, both echogenic and stimulating needles had better visibility (score of 2 or 3) under ultrasound, probably because of the Tuohy tip and the larger bore of the needles used in both our groups. Our patient population also had a significantly higher BMI, and we used a low-frequency curved array probe. The visibility scores in both the groups were similar in our study, possibly because we used a larger-bore needle to allow catheter insertion, unlike that of Hebard and Hocking, 2 who used smaller-gauge single-injection block needles. We found that fewer needle redirections (a mean of 1.8 vs 0.77) were needed with the echogenic needles, which may have been because of increased difficulty in obtaining good alignment of the needle and the probe in the Stimulating group. This might be a surrogate marker of poorer visibility of the non-echogenic needle, not reflected in assessment of the recorded images by the independent observers. One of our interests was to see whether catheter tip visibility could be improved with the echogenic technology, but this was not found to be the case. One of the reasons for this could be our inability to align the US beam precisely with the catheter tip during a deep block with a curved low-frequency probe.
Use of a stimulating catheter was associated with a trend towards a lower failure rate at the expense of increased procedure time and patient discomfort. The number of needle redirects and longer procedure time themselves might have contributed to the patient discomfort. Our results are similar to other studies comparing US-guided blocks with or without neurostimulation, where persistence in achieving optimal neurostimulation resulted in a longer procedure time without improvement of success rates. 22 23 Although up to a quarter of the blocks were incomplete at 30 min (Echogenic group 25.7%, Stimulating group 23.7%), testing beyond 30 min might have captured delayed completion of the blocks. Although our study is not powered to detect significant differences between the groups with regard to failure, it is interesting to note four failures (11%) in the Echogenic group and no failures in the Stimulating group. This could be attributable to the use of neurostimulation for catheter placement in the Stimulating group, which has an objective end point (twitches or no twitches). In a purely US-guided catheter placement, as was done in the Echogenic group, the catheter is placed using direct visual assessment of the tip and catheter-nerve interaction, which are subjective end points.
There are some limitations to our study. It was not powered to detect differences in complication rates between the two groups. Analgesic efficacy and block parameters in the postoperative period were not examined in this study; the primary outcome was the visibility of the needle. The US image evaluators could have been alerted to group allocation for some participants because of the characteristic appearance of the echogenic needles under ultrasound. Future studies comparing the safety and analgesic efficacy of stimulating and echogenic systems with or without the use of neurostimulation are needed, with an appropriate sample size.
The two different kits (echogenic and non-echogenic) used in our study were priced very closely; the echogenic kit cost $0.15 (<0.25%) more than the stimulating kit. Choices in selection of the kit are therefore likely to be made on the basis of clinical and technical reasons rather than financial ones.
In conclusion, use of echogenic needles and catheters reduced the number of needle passes, procedure time, and patient discomfort compared with a stimulating catheter system. There were no differences in the visibility scores of the two systems.
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